Nabla Bio
Nabla is an autoreverse platform that enables the rapid discovery of previously unattainable protein variants with supernatural qualities. Nabla Bio makes new medicines and improve nutrition by engineering novel proteins.
Biopharma Biotechnology Machine Learning
Funding Amount: $26M
Funding Type: Series A
Funding Date: 2024-05-15
City & State: Boston, Massachusetts
Country United States
Employee Count: 15
Similar Startups
Hebbia
Hebbia is the interface for AGI– the first AI platform that works the way humans work. Designed to tackle even the most complex tasks, it turns prompts into processes that AI agents complete.
Axelera AI
Axelera AI is an artificial intelligence chip manufacturer that creates AI hardware and software platforms for edge computing. It aims to produce the world’s most efficient and advanced solutions for AI at the edge.
Innatera
Innatera is a trailblazing developer of ultra-low power intelligence for sensors. Incorporated in 2018 as a spin-off from the Delft University of Technology, it develops a line of neuromorphic processors that mimic the mechanisms the brain uses for sensory perception.
Sensi.AI
Sensi.Ai developed the first audio AI that's able to analyze the routine in long term care environments, detect anomalies and provide insight on trends, with the purpose of improving the quality of care.